261 related articles for article (PubMed ID: 8647969)
1. Psychodermatology: an update.
Gupta MA; Gupta AK
J Am Acad Dermatol; 1996 Jun; 34(6):1030-46. PubMed ID: 8647969
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drugs in dermatology. A review and guidelines for use.
Gupta MA; Gupta AK; Haberman HF
J Am Acad Dermatol; 1986 Apr; 14(4):633-45. PubMed ID: 2870093
[TBL] [Abstract][Full Text] [Related]
3. Psychodermatology. Practical guidelines on pharmacotherapy.
Koo JY; Pham CT
Arch Dermatol; 1992 Mar; 128(3):381-8. PubMed ID: 1550372
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic Drugs in Dermatology.
Rodríguez Martín AM; González Padilla M
Actas Dermosifiliogr; 2015; 106(6):507-9. PubMed ID: 25500140
[No Abstract] [Full Text] [Related]
5. Psychopharmacological therapies in dermatology.
Wong JW; Koo JY
Dermatol Online J; 2013 May; 19(5):18169. PubMed ID: 24011270
[TBL] [Abstract][Full Text] [Related]
6. Therapy in psychosomatic dermatology.
Sarti MG; Cossidente A
Clin Dermatol; 1984; 2(4):255-73. PubMed ID: 6152774
[No Abstract] [Full Text] [Related]
7. Use of psychiatric drugs in Dermatology.
Weber MB; Recuero JK; Almeida CS
An Bras Dermatol; 2020; 95(2):133-143. PubMed ID: 32171543
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacology in psychodermatology.
Shukla R; Sasseville D
J Cutan Med Surg; 2008; 12(6):255-67. PubMed ID: 19317947
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic drugs: uses in medical and psychosomatic disorders.
Rees WL
Psychosomatics; 1979 Dec; 20(12):837-9. PubMed ID: 42942
[No Abstract] [Full Text] [Related]
10. [Psychodermatology].
Gieler U; Harth W
Hautarzt; 2008 Apr; 59(4):287-8. PubMed ID: 18340415
[No Abstract] [Full Text] [Related]
11. Use of psychotropic drugs in the dermatology patient: When to start and stop?
Shah B; Levenson JL
Clin Dermatol; 2018; 36(6):748-755. PubMed ID: 30446199
[TBL] [Abstract][Full Text] [Related]
12. Psychogenic Itch Management.
Szepietowski JC; Reszke R
Curr Probl Dermatol; 2016; 50():124-32. PubMed ID: 27578081
[TBL] [Abstract][Full Text] [Related]
13. Neurotropic and psychotropic drugs in dermatology.
Tennyson H; Levine N
Dermatol Clin; 2001 Jan; 19(1):179-97, x. PubMed ID: 11155582
[TBL] [Abstract][Full Text] [Related]
14. Rational use of psychotropic drugs. II. Antianxiety agents.
Greenblatt DJ; Shader RI
J Maine Med Assoc; 1974 Sep; 65(9):225-9. PubMed ID: 4153460
[No Abstract] [Full Text] [Related]
15. The use of psychotropic drugs in dermatology.
Gupta MA; Gupta AK
Dermatol Clin; 2000 Oct; 18(4):711-25, x. PubMed ID: 11059379
[TBL] [Abstract][Full Text] [Related]
16. Estimated Frequency of Psychodermatologic Conditions in Alberta, Canada.
Turk T; Dytoc M; Youngson E; Abba-Aji A; Mathura P; Fujiwara E
J Cutan Med Surg; 2021; 25(1):30-37. PubMed ID: 32880195
[TBL] [Abstract][Full Text] [Related]
17. The use of psychotropic medications in clinical dermatology.
Koo JY
Dermatol Clin; 1992 Jul; 10(3):641-5. PubMed ID: 1352190
[TBL] [Abstract][Full Text] [Related]
18. Psychopharmacology in pregnancy.
Gjere NA
J Perinat Neonatal Nurs; 2001 Mar; 14(4):12-25. PubMed ID: 11930520
[TBL] [Abstract][Full Text] [Related]
19. Psychodermatology: a brief review for clinicians.
Buljan D; Buljan M; Situm M
Psychiatr Danub; 2005 Jun; 17(1-2):76-83. PubMed ID: 16395847
[TBL] [Abstract][Full Text] [Related]
20. Commentary: psychodermatology.
Gupta MA
Clin Dermatol; 2013; 31(1):1-2. PubMed ID: 23245967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
